SEC Filing Details
Document Details
Form
Filing Date
Aug 11, 2020
Document Date
Aug 10, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
NGM Biopharmaceuticals, Inc.
Issuer
NGM BIOPHARMACEUTICALS INC
Filer
CHEN JIN-LONG
Contact Information
Investor Relations:
ir@ngmbio.com
Media Relations:
media@ngmbio.com
Toolkit